Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, efficacy, and pharmacokinetics of EVOLVE104 in patients with advanced urothelial cancer and squamous cell carcinomas; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Squamous Cell Carcinoma
• Bladder Cancer
• Cervical Squamous Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma
• Esophageal Squamous Cell Carcinoma
• Oral Squamous Cell Carcinoma
• Penile Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• EVOLVE104

Snippet

Sponsor: EvolveImmune United, Inc | Conditions: Bladder Cancer, Squamous Cell Carcinoma of the Lung | Phase 1 | Status: RECRUITING